TY - JOUR
T1 - The influence of GDF11 on brain fate and function
AU - Schafer, Marissa J.
AU - LeBrasseur, Nathan K.
N1 - Funding Information:
Acknowledgments Research associated with this review was supported by the National Institutes of Health, National Institute on Aging through a Mayo Clinic Alzheimer's Research Center pilot grant from AG016574 (MJS) and grants AG055529 and AG052958 (NKL).
Publisher Copyright:
© 2019, American Aging Association.
PY - 2019/2/15
Y1 - 2019/2/15
N2 - Growth differentiation factor 11 (GDF11) is a transforming growth factor β (TGFβ) protein that regulates aspects of central nervous system (CNS) formation and health throughout the lifespan. During development, GDF11 influences CNS patterning and the genesis, differentiation, maturation, and activity of new cells, which may be primarily dependent on local production and action. In the aged brain, exogenous, peripherally delivered GDF11 may enhance neurogenesis and angiogenesis, as well as improve neuropathological outcomes. This is in contrast to a predominantly negative influence on neurogenesis in the developing CNS. Seemingly antithetical effects may correspond to the cell types and mechanisms activated by local versus circulating concentrations of GDF11. Yet undefined, distinct mechanisms of action in young and aged brains may also play a role, which could include differential receptor and binding partner interactions. Exogenously increasing circulating GDF11 concentrations may be a viable approach for improving deleterious aspects of brain aging and neuropathology. Caution is warranted, however, since GDF11 appears to negatively influence muscle health and body composition. Nevertheless, an expanding understanding of GDF11 biology suggests that it is an important regulator of CNS formation and fate, and its manipulation may improve aspects of brain health in older organisms.
AB - Growth differentiation factor 11 (GDF11) is a transforming growth factor β (TGFβ) protein that regulates aspects of central nervous system (CNS) formation and health throughout the lifespan. During development, GDF11 influences CNS patterning and the genesis, differentiation, maturation, and activity of new cells, which may be primarily dependent on local production and action. In the aged brain, exogenous, peripherally delivered GDF11 may enhance neurogenesis and angiogenesis, as well as improve neuropathological outcomes. This is in contrast to a predominantly negative influence on neurogenesis in the developing CNS. Seemingly antithetical effects may correspond to the cell types and mechanisms activated by local versus circulating concentrations of GDF11. Yet undefined, distinct mechanisms of action in young and aged brains may also play a role, which could include differential receptor and binding partner interactions. Exogenously increasing circulating GDF11 concentrations may be a viable approach for improving deleterious aspects of brain aging and neuropathology. Caution is warranted, however, since GDF11 appears to negatively influence muscle health and body composition. Nevertheless, an expanding understanding of GDF11 biology suggests that it is an important regulator of CNS formation and fate, and its manipulation may improve aspects of brain health in older organisms.
KW - Alzheimer’s disease
KW - Brain aging
KW - Brain development
KW - GDF11
KW - Growth differentiation factor 11
KW - Neurogenesis
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85061234614&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061234614&partnerID=8YFLogxK
U2 - 10.1007/s11357-019-00054-6
DO - 10.1007/s11357-019-00054-6
M3 - Review article
C2 - 30729414
AN - SCOPUS:85061234614
SN - 2509-2715
VL - 41
JO - GeroScience
JF - GeroScience
IS - 1
ER -